MOTS-C UK: Research Reference 2026

MOTS-C (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. First identified in 2015 by Lee et al., MOTS-C represents a novel class of mitochondrial-derived peptides (MDPs) that act as signalling molecules between mitochondria and the nucleus, coordinating cellular metabolic responses to stress and environmental challenges.

Unlike nuclear-encoded peptides, MOTS-C is translated from mitochondrial DNA within the mitochondrial matrix, then exported to the cytosol and extracellular space. The peptide has been identified as a regulator of metabolic homeostasis, cellular stress responses, and mitochondrial-nuclear communication.

For UK research laboratories, MOTS-C serves as a reference compound for studies examining mitochondrial signalling, metabolic regulation, and the role of mitochondrial-derived peptides in cellular homeostasis. The peptide is particularly relevant for research into metabolic flexibility, insulin sensitivity, and cellular stress responses.

MOTS-C is a small peptide with distinct structural characteristics:

• Sequence: 16 amino acids (MRWQEMGYIFYPRKLN)
• Molecular weight: Approximately 2,099 Da
• Origin: Encoded by the mitochondrial 12S rRNA gene
• Processing: Cleaved from the mitochondrial ORF to generate the active 16-residue peptide
• Location: Synthesised within mitochondria; exported to cytosol and extracellular space
• Stability: Relatively short half-life due to small size; peptide bonds may be susceptible to proteolytic degradation

The peptide's small size and hydrophobic character influence its cellular penetration and interaction with membrane receptors. The N-terminal region contains a putative signal sequence that may facilitate mitochondrial export.

MOTS-C operates through several distinct mechanisms in cellular and in vitro models:

Metabolic Regulation

MOTS-C regulates metabolic pathways through activation of AMP-activated protein kinase (AMPK). In cellular studies, the peptide increases AMPK phosphorylation, leading to downstream effects on glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. The AMPK activation is independent of the canonical energy-sensing pathway, suggesting a novel mechanism of kinase regulation.

Mitochondrial-Nuclear Communication

As a mitochondrial-encoded peptide, MOTS-C represents a retrograde signalling molecule that communicates mitochondrial status to the nucleus. In cellular models, MOTS-C translocates to the nucleus and modulates gene expression programmes related to metabolism, stress resistance, and cellular senescence. This retrograde signalling provides a mechanism for mitochondria to coordinate cellular responses to metabolic stress.

Cellular Stress Response

MOTS-C is upregulated in response to metabolic stress, including glucose deprivation, oxidative stress, and mitochondrial dysfunction. In cellular studies, the peptide confers resistance to metabolic stress by enhancing glucose uptake and optimising mitochondrial function. The stress-responsive nature suggests a physiological role in maintaining cellular homeostasis during metabolic challenges.

Insulin Sensitivity

In cellular and animal models, MOTS-C improves insulin sensitivity through multiple pathways. The peptide enhances glucose uptake in skeletal muscle cells and adipocytes, reduces hepatic glucose production in hepatocyte cultures, and modulates adipokine secretion. These effects are mediated through AMPK activation and downstream metabolic pathways.

MOTS-C is employed across multiple research domains in UK laboratories:

Metabolic Disease Research

In vitro studies examine MOTS-C's effects on glucose metabolism, insulin signalling, and lipid oxidation in cellular models. Researchers use the peptide to study mitochondrial regulation of metabolic pathways, examining how mitochondrial-derived signals influence nuclear gene expression and cellular metabolism.

Ageing and Cellular Senescence

Cellular senescence models examine MOTS-C's effects on senescence markers, telomere maintenance, and stress resistance. The peptide's stress-responsive nature and AMPK activation make it relevant for research into cellular ageing mechanisms and longevity pathways.

Mitochondrial Biology

MOTS-C serves as a tool compound for studying mitochondrial-nuclear communication, mitochondrial-derived signalling, and the role of mitochondrial DNA-encoded peptides in cellular regulation. Research questions examine how mitochondrial status is communicated to the nucleus and how this signalling influences cellular adaptation.

Exercise Physiology

In cellular models, MOTS-C is studied in the context of exercise-mimetic effects. The peptide activates AMPK and enhances metabolic flexibility, creating research questions about whether mitochondrial-derived peptides mediate some of the metabolic benefits of physical activity.

Comparative Mitochondrial Peptides

MOTS-C is compared to other mitochondrial-derived peptides (humanin, SHLPs) in cellular studies. Research questions examine whether different MDPs have distinct or overlapping functions in metabolic regulation and stress responses.

UK research laboratories employ several standard cellular models for MOTS-C studies:

Glucose Uptake Assays

Differentiated muscle cells (C2C12 myotubes) and adipocytes (3T3-L1) are used to measure glucose uptake in response to MOTS-C. Endpoints include 2-deoxyglucose uptake, GLUT4 translocation, and insulin sensitivity indices. MOTS-C is compared to insulin and AMPK activator controls.

AMPK Activation Studies

Cellular models measure AMPK phosphorylation (Thr172) and downstream substrate phosphorylation (ACC, Raptor) in response to MOTS-C treatment. The peptide's mechanism of AMPK activation is studied in comparison to canonical AMPK activators (AICAR, metformin, A-769662).

Mitochondrial Function

Primary cells and cell lines with defined mitochondrial backgrounds are used to examine MOTS-C's effects on mitochondrial respiration, ATP production, and reactive oxygen species generation. Seahorse respirometry and fluorescent probes are standard endpoints.

Nuclear Translocation

Immunofluorescence and subcellular fractionation studies track MOTS-C movement from mitochondria to nucleus in live cells. The kinetics and conditions of nuclear translocation are examined in response to metabolic stress and peptide treatment.

Gene Expression

RNA-seq and qPCR approaches identify gene expression changes induced by MOTS-C in cellular models. The transcriptional signature is compared to other metabolic regulators and mitochondrial stressors.

MOTS-C's safety profile is based on preclinical cellular and animal studies. In vitro toxicology screens using standard cell lines have not identified significant cytotoxicity at research-relevant concentrations (up to 100 μM).

In animal studies, MOTS-C administration has been well tolerated, with no significant adverse effects reported at standard research doses. The peptide's endogenous nature and small size contribute to favourable safety characteristics. However, the short half-life and rapid clearance may require frequent dosing or modified formulations in research protocols.

The peptide's AMPK activation raises theoretical concerns about excessive metabolic activation, though no adverse metabolic effects have been reported at standard research doses. As with all research peptides, appropriate laboratory controls and dose-ranging studies are recommended.

Standard laboratory precautions apply: MOTS-C is a research peptide, not a medicine or dietary supplement. It is supplied for in vitro and laboratory animal research only.

MOTS-C is supplied as a lyophilised powder in research-grade vials. Standard laboratory preparation:

• Reconstitution: Bacteriostatic water (0.9% benzyl alcohol) is recommended for laboratory preparations
• Concentration: Typical research stock concentrations range from 1–10 mg/mL depending on assay requirements
• Storage: Lyophilised powder at −20 °C; reconstituted solution at 2–8 °C, protected from light
• Stability: Reconstituted solutions are stable for 7–14 days under refrigeration; for extended studies, aliquot and freeze at −20 °C
• Solubility: The peptide is generally soluble in aqueous solutions; brief vortexing may aid dissolution
• Protease sensitivity: Due to small size, MOTS-C may be susceptible to proteolytic degradation; protease inhibitors may be included in incubation media

The peptide's small size may result in non-specific binding to plastic surfaces; researchers should verify recovery rates in their specific assay formats. Pre-wetting tubes with BSA-containing buffer may reduce peptide loss.

MOTS-C is not a controlled substance under the UK Misuse of Drugs Act 1971 and is not scheduled under the Psychoactive Substances Act 2016. It is classified as a research peptide for laboratory use and is not licensed as a medicine by the MHRA.

For UK research laboratories, MOTS-C is available as a research-grade reference material. Sourcing should include:

• Certificate of Analysis confirming ≥98% purity (HPLC)
• Mass spectrometry identity confirmation (molecular weight ~2,099 Da)
• Batch-specific testing documentation
• Appropriate storage and shipping conditions (cold chain)
• Research-use-only labelling

Researchers should ensure compliance with institutional ethics approvals for animal studies, and adhere to standard laboratory safety protocols for peptide handling.